Sharekhan

Nureca Ltd

Fri 17/10/2025,15:57:8 | NSE : NURECA

₹ 289.2246.79 (19.30%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 269.99

Previous Close

₹ 242.43

Volume

844529

Mkt Cap ( Rs. Cr)

₹289.23

High

₹ 290.91

Low

₹ 261.20

52 Week High

₹ 447.50

52 Week Low

₹ 203.62

Book Value Per Share

₹ 194.30

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Nureca Ltd

Your Vote -

Buy

35.90%

Hold

3.42%

Sell

60.68%

35.90%

117 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

289.22

31869

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

31869

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Nureca Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Nureca Ltd - Copy of Newspaper Publication

    17 Oct 2025, 4:55PM Nureca Limited has informed the Exchange about Copy of Newspaper Publication
  • Nureca Ltd - Intimation Of Securities And Exchange Board Of India ('SEBI') Order Under Section 11(1) Of SEBI Act, 1992 Read W

    17 Oct 2025, 3:26PM Intimation of Securities and Exchange Board of India (\SEBI\) Order under Section 11(1) of SEBI Act, 1992 read with Regulation 28 of SEBI (Buy-Back Se
  • Nureca Ltd - General Updates

    17 Oct 2025, 3:21PM Nureca Limited has informed the Exchange about ""Intimation of Securities and Exchange Board of India ( SEBI ) Order under Section 11(1) of SEBI Act,
  • Nureca Ltd - General Updates

    16 Oct 2025, 7:40PM Nureca Limited has informed the Exchange about General Updates-Financial Results for the Quarter and Half year ended 30th September,2025.
  • Nureca Ltd - Nureca Limted Has Informed The Exchange Regarding Financial Results For The Quarter And Half Year Ended 30Th Sep

    16 Oct 2025, 7:17PM Nureca Limited has informed the exchange regarding Financial Results for the quarter and half year ended 30th September,2025.
  • Nureca Ltd - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    16 Oct 2025, 6:13PM Nureca Limited has informed the regarding Press Release
  • Nureca Ltd - Announcement under Regulation 30 (LODR)-Investor Presentation

    16 Oct 2025, 6:12PM Nureca Limited has informed the exchange regardig Investor Presentation.
  • Nureca Ltd - Updates

    16 Oct 2025, 6:08PM Nureca Limited has informed the Exchange regarding 'Nureca Limited has informed the exchange regarding Investor Presentation'.
  • Nureca Ltd - Press Release

    16 Oct 2025, 6:02PM Nureca Limited has informed the Exchange regarding a press release dated October 16, 2025, titled "" Nureca Limited reports 21% YoY growth for Q2 FY26
  • Nureca Ltd posts Q2 net profit of Rs 3.14 cr

    16 Oct 2025, 5:50PM The company reported standalone net profit during the quarter stood at Rs 3.14 crore compared to net loss of Rs 0.65 crore in the previous year quarte
  • Nureca Ltd - Outcome of Board Meeting

    16 Oct 2025, 5:50PM Nureca Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
  • Nureca Ltd - Board Meeting Outcome for Nureca Limited Has Informed The Exchange Regarding Financial Results For The Quarter A

    16 Oct 2025, 5:42PM Nureca Limited has informed the exchange regarding Financial results for the quarter and half year ended 30th September,2025.
  • Nureca Ltd - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    15 Oct 2025, 2:40PM Nureca Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
  • Nureca Ltd - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    15 Oct 2025, 2:45PM Nureca Limited has informed the exchange regarding certificate under Reg 74(5) of SEBI(DP ) Regulations ,2018
  • Nureca Ltd - Announcement under Regulation 30 (LODR)-Change in Management

    11 Oct 2025, 6:42PM Nureca Limited has informed the exchange regarding resignation of Chief Financial Officer.
  • Nureca Ltd - Resignation

    11 Oct 2025, 6:34PM Nureca Limited has informed the Exchange regarding Resignation of NARESH GUPTA as Chief Financial Officer of the company w.e.f. January 09, 2026.
  • Nureca Ltd - Board Meeting Intimation for Nureca Limited Has Informed The Exchange Regarding Intimation Of Board Meeting For

    10 Oct 2025, 8:39PM Nureca Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/10/2025 ,inter alia, to consider and approve N
  • Nureca Ltd - Trading Window

    29 Sep 2025, 6:03PM Nureca Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
  • Nureca Ltd - Filing Of Scheme Under Regulation 37(6) Of The Securities And Exchange Board Of India (Listing Obligations And D

    24 Jul 2025, 11:40AM Filing of Scheme under Regulation 37(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements ) Regulations,2
  • Nureca hit 5% upper circuit

    24 Jun 2021 , 2:47PM Hornbill Orchid India picks up 2% stake in Nureca

Key fundamentals

Evaluate the intrinsic value of Nureca Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 194.002 193.261 195.263 203.743 166.774
Liabilities 194.002 193.261 195.263 203.743 166.774
Equity 10 10 10 10 10
Gross Profit -9.732 -11.131 -15.39 55.773 61.682
Net Profit -0.668 -2.442 -8.422 45.309 46.534
Cash From Operating Activities -18.548 -2.997 12.051 1.827 35.101
NPM(%) -0.58 -2.58 -7.52 17.73 21.81
Revenue 114.64 94.521 111.899 255.549 213.331
Expenses 124.372 105.652 127.289 199.776 151.649
ROE(%) -0.34 -1.25 -4.33 23.31 23.94

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
24 Feb 2022 3 30 0 1489.5
21 Sep 2021 2 20 0 1546.25

Peers

Other companies within the same industry or sector that are comparable to Nureca Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Procter and Gamble Hygiene and Healthcare Ltd 13758.00 -2.31 53.89 934.20 1961.11 1.27
Godrej Industries Ltd 1081.90 -0.06 36.15 9693.10 2913.81 0.00
Colgate-Palmolive (India) Ltd 2295.30 0.42 44.80 7828.16 5282.67 2.22
Shanthala FMCG Products Ltd 31.00 -5.20 21.53 192.77 14.41 0.00

Company Info

The Company was incorporated as `Nureca Private Limited', as a private limited company, under the Companies Act, 2013 on November 2, 2016 and a certificate of incorporation was issued by Registrar of Companies, Central Registration Centre, at Delhi. The registered office of the Company was changed from Delhi to Mumbai, Maharashtra, pursuant to certificate of registration of regional director order dated January 8, 2019 for change of state issued by the RoC with effect from February 8, 2019. Upon to conversion into a public limited company pursuant to a special resolution passed in the extra ordinary general meeting of the shareholders of the Company held on June 19, 2020, the name of the Company was changed to the present name `Nureca Limited' and a fresh certificate of incorporation was issued by the RoC on July 8, 2020.The Company became a wholly owned Subsidiary of Nectar Biopharma Private Limited on August 16, 2018. Pursuant to the Scheme of Arrangement approved by the NCLT, Special Bench, Mumbai vide its order dated April 29, 2020, the Specified Undertaking (as defined in the Scheme of Arrangement) was demerged from Nectar Biopharma Private Limited and vested into the Company. Consequently, 1 equity share of face value Rs.10 each of the Company was issued to each shareholders of Nectar Biopharma Private Limited for every 1 equity shares of face value Rs.10 each, held by them in Nectar Biopharma Private Limited as on the record date, i.e. June 9, 2020.Major Events and Milestones :2016- Online launch of Dr. Trust Brand.2017- Launched Dr. Physio brand in electric massager categories and Trumom brand in mother and child care categories.- Started three flex centres in Punjab, Karnataka and Uttar Pradesh.2018- The Company became the wholly owned subsidiary of Nectar Biopharma Private Limited.- Added three flex centres in Chandigarh, Telangana and Maharashtra.- Secured warehouse drug license.2020- Transfer and vesting of Specified Undertaking (as defined under the Scheme) from Nectar Biopharma Private Limited to the Company pursuant to the Scheme of Arrangement.

The Company was incorporated as `Nureca Private Limited', as a private limited company, under the Companies Act, 2013 on November 2, 2016 and a certificate of incorporation was issued by Registrar of Companies, Central Registration Centre, at Delhi. The registered office of the Company was changed from Delhi to Mumbai, Maharashtra, pursuant to certificate of registration of regional director order dated January 8, 2019 for change of state issued by the RoC with effect from February 8, 2019. Upon to conversion into a public limited company pursuant to a special resolution passed in the extra ordinary general meeting of the shareholders of the Company held on June 19, 2020, the name of the Company was changed to the present name `Nureca Limited' and a fresh certificate of incorporation was issued by the RoC on July 8, 2020.The Company became a wholly owned Subsidiary of Nectar Biopharma Private Limited on August 16, 2018. Pursuant to the Scheme of Arrangement approved by the NCLT, Special Bench, Mumbai vide its order dated April 29, 2020, the Specified Undertaking (as defined in the Scheme of Arrangement) was demerged from Nectar Biopharma Private Limited and vested into the Company. Consequently, 1 equity share of face value Rs.10 each of the Company was issued to each shareholders of Nectar Biopharma Private Limited for every 1 equity shares of face value Rs.10 each, held by them in Nectar Biopharma Private Limited as on the record date, i.e. June 9, 2020.Major Events and Milestones :2016- Online launch of Dr. Trust Brand.2017- Launched Dr. Physio brand in electric massager categories and Trumom brand in mother and child care categories.- Started three flex centres in Punjab, Karnataka and Uttar Pradesh.2018- The Company became the wholly owned subsidiary of Nectar Biopharma Private Limited.- Added three flex centres in Chandigarh, Telangana and Maharashtra.- Secured warehouse drug license.2020- Transfer and vesting of Specified Undertaking (as defined under the Scheme) from Nectar Biopharma Private Limited to the Company pursuant to the Scheme of Arrangement.

Read More

Parent Organisation

Nureca Ltd.

Founded

02/11/2016

Managing Director

Mr.Saurabh Goyal

NSE Symbol

NURECAEQ

FAQ

The current price of Nureca Ltd is ₹ 289.22.

The 52-week high for Nureca Ltd is ₹ 290.91 and the 52-week low is ₹ 261.20.

The market capitalization of Nureca Ltd is currently ₹ 289.23. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Nureca Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Nureca Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Nureca Ltd shares.

The CEO of Nureca Ltd is Mr.Saurabh Goyal, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT